Safety and Efficacy analysis of 10 mg donepezil for severe Alzheimer's disease: switch from the other cholineseterase inhibitors
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000008971
- Lead Sponsor
- epartment of Neurology, Juntendo University School of Medicine
- Brief Summary
Sufficient number of subjects did not complete this study because people with severe dementia stopped to visit the hospital.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with dementia except AD 2.Patients with high serum Vitamine level 3.Patients who are allergic to donepezil
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mini Mental state examination
- Secondary Outcome Measures
Name Time Method europsychiatric Inventory